SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT)
0 references·16 citing·40 second hop
Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Trends in risk of transfusion-transmitted…An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study (2021)An international comparison o…10‐year analysis of human immunodeficiency virus incidence in first‐time and repeat donors in Brazil (2020)10‐year analysis of human imm…Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey. (2018)Prevalence, incidence and res…Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Residual risk of transmission…Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Nucleic acid amplification te…Surveillance of Transfusion-Transmissible Infections (2011)Surveillance of Transfusion-T…Deferral from donating blood of men who have sex with men: impact on the risk of HIV transmission by transfusion in France (2011)Deferral from donating blood …[Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors]. (2011)[Safe blood in the absence of…Estimation quantitative du risque de contamination d’un don de sang par des agents infectieux (2009)Estimation quantitative du ri…Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections (2008)Human immunodeficiency virus …Current information on the infectious risks of allogeneic blood transfusion (2008)Current information on the in…Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201 (2008)Comparison of the analytical …Trends in HIV prevalence in blood donations in Europe, 1990–2004 (2007)Trends in HIV prevalence in b…Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)Residual risk of transfusion‐…Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors (2006)Lessons and opportunities fro…Developing an administrative plan for transfusion medicine—a global perspective (2005)Developing an administrative …The Risk of Transfusion-Transmitted Viral Infections (1996)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Blood supply safety: an NHLBI perspective (2008)Evolving deferral criteria for blood donation in France: Plasma donation by men who have sex with men (2023)Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes (2009)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture (2012)Blood banking in China (2002)Paying for blood donations: still a risk? (2002)Safety of the Blood Supply in Latin America (2005)Availability of blood components and plasma derived medicines in Iran (2007)Prevalência de doação de sangue e fatores associados em Florianópolis, Sul do Brasil: estudo de base populacional (2013)Dynamic temporary blood facility location-allocation during and post-disaster periods (2017)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Évolutions technologiques en qualification biologique du don et leur impact sur le risque résiduel transfusionnel (2011)Estimation d’un risque transfusionnel émergent : l’exemple du VHE (2014)Residual Risk of Transmission of HIV and Hepatitis B and C by Blood Transfusion in Bukavu in the Democratic Republic of Congo (2014)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four chinese regional blood centers between 2000 and 2010 (2012)The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi’an, China between 1999 and 2009 (2012)Blood safety and availability: continuing challenges in C hina's blood banking system (2013)Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 2000 (2002)The impact of male‐to‐male sexual experience on risk profiles of blood donors (2005)If the permanent deferral were lifted would men who have sex with men want to donate blood, and if so, who would be eligible? (2013)The rates, perceptions, and willingness of men who have sex with men to donate blood (2014)Transmission of human immunodeficiency virus T ype‐1 by fresh‐frozen plasma treated with methylene blue and light (2015)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting (2022)A comparative analysis between NAT and chemiluminescence in detection of transfusion transmitted viruses in two main university blood transfusion centers (2025)Risks and challenges of HIV infection transmitted via blood transfusion (2019)Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003-2017). (2019)Transfusion Transmissible Infections in Blood Donors in the Province of Bié, Angola, during a 15-Year Follow-Up, Imply the Need for Pathogen Reduction Technologies (2021)Cost‐effectiveness of questionnaires in preventing transfusion‐transmitted infections (2013)Risk‐based decision making in transfusion medicine (2018)Transfusion of HIV‐infected blood products despite highly sensitive nucleic acid testing (2019)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2007Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 200470 cited
  • 2008Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 20152 cited
  • 2017Nucleic acid amplification testing in Indian blood banks: A review with perspectives39 cited
  • 2018Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey.39 cited
  • 2011Deferral from donating blood of men who have sex with men: impact on the risk of HIV transmission by transfusion in France29 cited
  • 2005Developing an administrative plan for transfusion medicine—a global perspective29 cited
  • 2011Surveillance of Transfusion-Transmissible Infections27 cited
  • 2008Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections26 cited
  • 2017Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil25 cited
  • 2009Estimation quantitative du risque de contamination d’un don de sang par des agents infectieux24 cited
  • 2008Current information on the infectious risks of allogeneic blood transfusion19 cited
  • 2007Trends in HIV prevalence in blood donations in Europe, 1990–2004

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

17 cited
  • 2021An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study13 cited
  • 202010‐year analysis of human immunodeficiency virus incidence in first‐time and repeat donors in Brazil13 cited
  • 2011[Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].12 cited
  • 2006Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors10 cited